In the absence of high-quality evidence, individualized monitoring and treatment of hypertension in cancer patients and survivors may be paramount, according to a state-of-the-art review published Dec. 17 in JACC: CardioOncology. Jordana B. Cohen, MD, MSCE, et al., provide a call for action for improved hypertension identification, treatment and control among…
In this week’s View, Dr. Eagle looks at a sex-based analysis of short-term dual antiplatelet therapy (DAPT) in patients receiving percutaneous coronary intervention (PCI) who…
When you become a member of the American College of Cardiology, you join a global community of cardiovascular professionals driven to transform cardiovascular care and…
Chicago Community Health Fair: Improving Heart Health For All
Submit Your LBCT Transform the future of CV care by presenting your Late-Breaking Clinical Trial research at ACC.25. Submissions due by 1 p.m. ET on…
A polypill for cardiovascular disease may be cost saving and a high value treatment in a low-income, majority Black population with limited health care access…
In this episode, hosted by the ACC Women in Cardiology (WIC) Advocacy Work Group, Drs. Kamala Tamirisa and Keerthana Pakanati welcome distinguished guests Drs. Lipi…
Randomized tria ls have shown that in patients with acute intermediate-high risk pulmonary embolism (PE), administration of systemic thrombolytics leads to less clinical deterioration, at…
The Engage Stage and Heart2Heart Stage combine to offer attendees unique and interactive ways to learn and connect over the course of ACC.25. In addition,…
In this week’s View, Dr. Eagle looks at the optimal threshold for identifying a myocardial infarction (MI) after PCI. He then discusses myocardial fibrosis and…
Please take the time to complete our survey. Your feedback is important.
